John Eikelboom, MD, explores the COMPASS trial and how healthcare providers can prevent major cardiovascular and limb events in patients with stable atherosclerotic vascular disease.

Presented on March 29 at NATF’s spring program: “Vascular Protection: What Every Patient, Physician, Pharmacist, and Nurse Needs to Know”